Jacobs & Co/Ca’s Eli Lilly & Co Position
Does Jacobs & Co/Ca own Eli Lilly & Co (LLY)? Yes — 29.0K shares worth $35M (+2.98% of its 13F portfolio) as of Q2 2026, down from 30.8K shares the prior filed quarter.
Position Value
$35M
Q2 2026
Shares
29.0K
% of Portfolio
+2.98%
Quarters Held
30
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 29.0K | $35M | +2.98% |
| Q1 2026 | 30.8K | $28M | +2.79% |
| Q4 2025 | 30.6K | $33M | +3.11% |
| Q3 2025 | 31.4K | $24M | +2.29% |
| Q2 2025 | 30.6K | $24M | +2.37% |
| Q1 2025 | 29.8K | $25M | +2.62% |
| Q4 2024 | 29.4K | $23M | +2.31% |
| Q3 2024 | 21.7K | $19M | +1.93% |
| Q2 2024 | 22.0K | $20M | +2.09% |
| Q1 2024 | 22.5K | $18M | +1.86% |
| Q4 2023 | 23.4K | $14M | +1.55% |
| Q3 2023 | 24.7K | $13M | +1.65% |
| Q2 2023 | 25.6K | $12M | +1.43% |
| Q1 2023 | 27.4K | $9M | +1.16% |
| Q4 2022 | 27.1K | $10M | +1.29% |
| Q3 2022 | 27.4K | $9M | +1.27% |
| Q2 2022 | 28.0K | $9M | +1.21% |
| Q1 2022 | 28.3K | $8M | +0.90% |
| Q4 2021 | 28.8K | $8M | +0.83% |
| Q3 2021 | 29.6K | $7M | +0.79% |
| Q2 2021 | 30.0K | $7M | +0.79% |
| Q1 2021 | 31.1K | $6M | +0.71% |
| Q4 2020 | 31.7K | $5M | +0.70% |
| Q2 2020 | 32.6K | $5M | +0.87% |
| Q1 2020 | 32.7K | $5M | +0.88% |
| Q4 2019 | 33.3K | $4M | +0.66% |
| Q3 2019 | 32.0K | $4M | +0.58% |
| Q2 2019 | 32.7K | $4M | +0.58% |
| Q1 2019 | 31.8K | $4M | +0.70% |
| Q4 2018 | 38.0K | $4M | +0.87% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Jacobs & Co/Ca’s full portfolio or all institutional holders of LLY.